These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7775 related articles for article (PubMed ID: 2175060)
1. Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level. Viale M; Ferrini S; Serrano S; Serrano D; Ardizzoni A; Nicolin A Tumori; 1990 Oct; 76(5):488-94. PubMed ID: 2175060 [TBL] [Abstract][Full Text] [Related]
2. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
3. Morphological and functional characteristics of tumor-infiltrating lymphocytes from human colorectal cancers after stimulation with rIL-2. Keller H; Wimmenauer S; Rahner S; Reimer P; von Kleist S; Farthmann EH Eur Surg Res; 1995; 27(4):258-68. PubMed ID: 7649213 [TBL] [Abstract][Full Text] [Related]
4. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. Miescher S; Whiteside TL; Moretta L; von Fliedner V J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380 [TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer. Pisani RJ; Krco CJ; Wold LE; McKean DJ Am J Clin Pathol; 1989 Oct; 92(4):435-46. PubMed ID: 2552792 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
7. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma. Facchetti P; Prigione I; Ghiotto F; Tasso P; Garaventa A; Pistoia V Cancer Immunol Immunother; 1996 Mar; 42(3):170-8. PubMed ID: 8640845 [TBL] [Abstract][Full Text] [Related]
8. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. Itoh K; Platsoucas CD; Balch CM J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710 [TBL] [Abstract][Full Text] [Related]
9. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Whiteside TL; Miescher S; Hurlimann J; Moretta L; von Fliedner V Cancer Immunol Immunother; 1986; 23(3):169-78. PubMed ID: 3024832 [TBL] [Abstract][Full Text] [Related]
10. Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer. Yano T; Yasumoto K; Togami M; Ishida T; Kimura G; Sugimachi K; Nomoto K Int J Cancer; 1989 Apr; 43(4):619-23. PubMed ID: 2495250 [TBL] [Abstract][Full Text] [Related]
11. Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes. Kuo SH; Chang DB; Lee YC; Lee YT; Luh KT Respirology; 1998 Mar; 3(1):55-9. PubMed ID: 9657662 [TBL] [Abstract][Full Text] [Related]
12. T Cells Expanded from PD-1 Li T; Zhao L; Yang Y; Wang Y; Zhang Y; Guo J; Chen G; Qin P; Xu B; Ma B; Zhang F; Shang Y; Li Q; Zhang K; Yuan D; Feng C; Ma Y; Liu Z; Tian Z; Li H; Wang S; Gao Q Cancer Res; 2021 Apr; 81(8):2184-2194. PubMed ID: 33408117 [TBL] [Abstract][Full Text] [Related]
13. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129 [TBL] [Abstract][Full Text] [Related]
14. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characterisation of tumour-infiltrating lymphocytes derived from thyroid tumours. Lee RS; Schlumberger M; Caillou B; Pages F; Fridman WH; Tartour E Eur J Cancer; 1996 Jun; 32A(7):1233-9. PubMed ID: 8758259 [TBL] [Abstract][Full Text] [Related]
16. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone. Katano M; Nagumo F; Kubota E; Yamamoto H; Matsuo T; Hisatsugu T; Tadano J Biotherapy; 1993; 6(1):25-32. PubMed ID: 8507542 [TBL] [Abstract][Full Text] [Related]
17. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC). Wang P; Vánky F; Klein E Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348 [TBL] [Abstract][Full Text] [Related]
18. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)]. Xu ZY Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):345-7. PubMed ID: 2177396 [TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody. Mansfield PF; Rosenblum MG; Murray JL; Itoh K Cancer Immunol Immunother; 1991; 33(4):247-54. PubMed ID: 1829394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]